From bombs to bromides? Trump’s jousting with biopharma may well boil down to a handshake on drug prices
A few months ago, the prospect of an executive order from President Donald Trump on drug pricing would have been the cause of high anxiety …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.